About

Matthew Allen, PhD, Head of Pharma at Cambridge Consultants, has overseen development projects on a broad range of devices, including nebulisers, dry powder inhalers, autoinjectors, implants and more. As Global Head of Pharma, Dr Allen leads in evolving Cambridge Consultants’ product development, engineering, design and scientific capabilities to meet the innovation needs of the pharma sector. He has a BSc and PhD in Surface Science.

Contributions

EXPERT VIEW

NEXT-GENERATION AUTOINJECTORS: BALANCING PATIENTS, PHARMA, PAYERS AND PLANET

David Latham, Matthew Allen and Charlie Dean use a case study of a reusable electromechanical autoinjector to outline the novel product development approach needed to achieve better outcomes for patients, pharma, payers and the planet.